NV

Neha Verma

Active Director Director DIN 07234184
DIN 07234184 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value •••• Premium profile

About Neha Verma

Data last updated:

Neha Verma is a Director at Rhythm Biotech Private Limited (since 2015). The company operates in Pharma. Rhythm Biotech Private Limited reported revenue of ₹1.25 Cr (FY 2023).

DIN 07234184
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2015
Oldest Company Age 11 yrs
Largest company Rhythm Biotech Private Limited · ₹1.25 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhythm Biotech Private Limited U51909HR2015PTC056501
Director26 Aug 20152015₹1.25 Cr (FY 2023)Active

Board colleagues of Neha Verma

NameDINCompanyDesignation
Sachin Kumar07234228Rhythm Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rhythm Biotech Private Limited
Premium access

Shareholding and investment profile for Neha Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Verma

Neha Verma currently holds 1 directorship: Rhythm Biotech Private Limited (Director, since 26 Aug 2015, revenue ₹1.25 Cr (FY 2023)).

Neha Verma was first appointed on 26 Aug 2015 as Director at Rhythm Biotech Private Limited.

The current boards of Neha Verma's companies include Sachin Kumar (Rhythm Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available